Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
The protein encoded by CCR9 is a member of the beta chemokine receptor family. Zusätzlich bieten wir Ihnen Chemokine (C-C Motif) Receptor 9 Antikörper (226) und und viele weitere Produktgruppen zu diesem Protein an.
Showing 4 out of 4 products:
There were significantly increased CCR9 protein levels in failing human hearts.
this study showed that CCR7 (zeige CCR7 Proteine) are overexpressed in CD4 (zeige CD4 Proteine)(-) CD8 (zeige CD8A Proteine)(-) thymocytes of myasthenia gravis patients.
Results indicated that the expression levels of CCR9 in lesional skin may be a useful biologic marker of the clinical efficacy of infliximab therapy in psoriasis patients.
Xray crystal structure of the CCR9 receptor in complex with vercirnon at 2.8 A resolution
that CCL25 (zeige CCL25 Proteine)/CCR9 signal may provide cancer cells with chemotactic abilities through influencing several epithelial-mesenchymal transitionmarkers
Studies indicate important roles played by chemokine ligand 25 (CCL25 (zeige CCL25 Proteine))/chemokine receptor 9 (CCR9) in tumorigenesis, tumor chemoresistance and metastasis.
CCR9 and Integrin-beta7 expression has a differential effect on graft fate during acute graft-versus-host disease (GVHD) of the liver depending on the GVHD target tissue.
CCR9 mRNA and protein levels were significantly increased in the nasopharyngeal carcinoma group compared with the control group.
CCR9-CCL25 (zeige CCL25 Proteine) interaction promoted proliferation and suppressed apoptosis of non-small cell lung cancer cells by activating the PI3K (zeige PIK3CA Proteine)/Akt (zeige AKT1 Proteine) pathway.
CCR9 could be beneficial in predicting lymph node metastasis, and it might act as a novel prognostic biomarker for lung adenocarcinoma.
these results showed a site- and cell-specific expressions of Ccl25 (zeige CCL25 Proteine) and its receptor Ccr9 within both maternal and embryonic compartments of implantation sites and suggested a role in inducing specific Ccr9+ leukocytes at the maternal-fetal interface during the initial steps of embryo implantation in the mouse model
Abrogation of CCR9 improved the post-myocardial infarction survival rate and left ventricular (LV) dysfunction and decreased the infarct size. The data reveal that CCR9 serves as a novel modulator of pathological progression following myocardial infarction through NF-kappaB (zeige NFKB1 Proteine) and MAPK (zeige MAPK1 Proteine) signaling.
Pressure overload-induced hypertrophy was greatly attenuated by CCR9 deficiency in cardiac-specific CCR9 knockout mice, whereas CCR9 overexpression in cardiac-specific transgenic mice strikingly enhanced cardiac hypertrophy.
CCR9 and CCL25 (zeige CCL25 Proteine) expressions are induced in the early stages of airway inflammation and they have an important role modulating eosinophils and lymphocytes recruitment at the first stages of inflammatory process
data indicate that in addition to acting as a gut (zeige GUSB Proteine)-homing molecule, CCR9 signaling shapes immune responses by inhibiting Treg cell development
Data suggest that blocking CC chemokine receptor 9 (CCR9) may represent a novel safe therapy for rheumatoid arthritis (RA).
activation of Notch1 (zeige NOTCH1 Proteine) has a dominant-negative effect on Ccr9 transcription and that Notch1 (zeige NOTCH1 Proteine) and E proteins control the dynamic expression of Ccr9 during T cell development.
CCR9/CCL25 (zeige CCL25 Proteine) is involved in acute skin transplantation rejection and anti-CCL25 (zeige CCL25 Proteine) strategies might be useful in preventing acute rejection.
Accumulated CD11b (zeige ITGAM Proteine)(+) macrophages are critical for activating hepatic stellate cells through the CCR9/CCL25 (zeige CCL25 Proteine) axis and therefore promote liver fibrosis.
The protein encoded by this gene is a member of the beta chemokine receptor family. It is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. Chemokines and their receptors are key regulators of the thymocytes migration and maturation in normal and inflammation conditions. The specific ligand of this receptor is CCL25. It has been found that this gene is differentially expressed by T lymphocytes of small intestine and colon, suggested a role in the thymocytes recruitment and development that may permit functional specialization of immune responses in different segment of the gastrointestinal tract. This gene is mapped to the chemokine receptor gene cluster region. Two alternatively spliced transcript variants have been described. Multiple transcript variants encoding different isoforms have been found for this gene.
C-C chemokine receptor type 9
, G protein-coupled receptor 28
, C-C CKR-9
, chemokine C-C receptor 10
, chemokine C-C motif receptor 9